Stock Trading CanaryHONG KONG · DIRECTORS' NOTICES
Cutia Therapeutics - B
02487 · Healthcare · Biotechnology
Score
Not ranked: no net buying on the exchange by a director in the last 180 days.
Price vs insider buying
2487.HK · HKD● Purchase × Sale ◇ Public disclosure ▥ 15-day cluster ·
Circles and crosses mark trade dates; diamonds below the axis mark later public disclosures. The trade became public on its disclosure date. Prices are nearest-session closes, not insider execution prices. Marker sizes are not compared when values or currencies differ.
Insider timeline
No purchase in the last 180 days; 1 insiders sold.
Tap an item for what it means.
×A sale
A cross is one insider's sales on one day. People sell to pay tax, to cash in share awards or to hold less of one company, so a sale says less than a purchase does. When someone bought and sold on the same day, the cross sits beside the dot. The totals are under “Purchases against sales” below.
Blue line: this share's price, −84.0% over these six months
The closing price of each day, from 4.45 on 2026-05-11 to 0.71 on 2026-11-05. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.
Who traded
| Insider | Role | Purchases | Sales | Bought | First purchase | Share price since |
|---|---|---|---|---|---|---|
| Zhang Lele | Board member | — | 3 | — | — | — |
Director trades on the exchange
Purchases and sales on the exchange in the last 12 months, as counted in the score.
| Trade date | Filed | Director | Held as | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|---|
| 2026-09-24 | 2026-09-25 | Zhang Lele | — | Sold | 653,800 | HK$1.01 | HK$658.4K |
| 2026-09-23 | 2026-09-25 | Zhang Lele | — | Sold | 113,400 | HK$1.06 | HK$120.7K |
| 2026-09-22 | 2026-09-25 | Zhang Lele | — | Sold | 136,800 | HK$1.08 | HK$148.3K |